ANGLE plc

ANGLE plc

ANGLE plc

Overview
Date Founded

2003

Headquarters

The Surrey Research Park,3 Frederick Sanger Road,Guildford, Surrey GU2 7YD

Type of Company

Public

Employees (Worldwide)

31

Industries

Management Consulting
Wholesale: Medical Supplies & Pharmaceuticals
Hospitals & Patient Services
Holding Companies
Commercial Scientific Research
Advertising & Marketing

Company Description

ANGLE Plc operates as a holding company, through its subsidiaries engages in providing products in cancer diagnostics and foetal health. Its main product is the Parsortix cell separation system, which can capture very rare cells from blood. The company was founded by Andrew D. W. Newland in April 1994 and is headquartered in Guildford, the United Kingdom.

Website

https://angleplc.com

In The News
See More News
RelSci
November 13, 2018
George E. Hvichia is no longer serving in their position at ANGLE plc
RelSci
November 13, 2018
Jan Groen is now serving in a new board position at ANGLE plc
PR Newswire
November 12, 2018
Global Liquid Biopsy Markets 2019-2023: Blood Tests Replace Surgical Biopsies, Single Screening Test for All Cancers Announced
PR Newswire
October 3, 2018
Global Liquid Biopsy Market to Grow Over $2.94 Billion by 2028, Reports BIS Research
PR Newswire
July 16, 2018
Global Liquid Biopsy Markets 2019-2023: Blood Tests Replace Surgical Biopsies & Single Screening Test for All Cancers Announced

Reveal deeper insights into your organization's relationships
with RelSci Contact Aggregator.

Empower Your Business Applications with Industry-Leading
Relationship Data from the RelSci API.

Get Contact Information on the
World's Most Influential Decision Makers.

Discover the Power of Your Network with
RelSci Premium Products.
Executives & Employees
See More
Andrew David William Newland

Founder

Ian Francis Griffiths

Chief Financial Officer, Secretary & Executive Director

Jay Lewington

Chief Technology Officer

Daniel J. O'Shannessy

Chief Scientific Officer

Paul Smith

Vice President, Chief Executive Officer Angle BioSciences, Inc

Martin Cooke

Director of Manufacturing & Regulatory Affairs

Michael O'Brien

Director-Business Development

Peggy Robinson

Vice President-NA

Brad Spitz

US Vice President Sales

M. Craig Miller

Clinical Studies Director

Board of Directors
Garth Robert Selvey

Former Chief Executive Officer at Comino Group Plc

Brian Howlett

Jan Groen

President, Chief Executive Officer & Executive Director at MDxHealth SA

Trending People
Amazon.com, Inc.
Amazon effect: A transit transformation, or just more traffic? - The Washington Post
The Boeing Company
MARKETS : Stocks fall along with oil prices - Los Angeles Times
European Union
'Insane' for UK and EU to harm border trade, McLaren CEO says - CNBC
JUUL Labs, Inc.
Juul halts store sales of some flavored e-cigarettes - Associated Press
US Department of Defense (District of Columbia)
Who is Mira Ricardel and why did Melania Trump want her fired? - CNN
Trending Organizations
Amazon.com, Inc.
Amazon effect: A transit transformation, or just more traffic? - The Washington Post
The Boeing Company
MARKETS : Stocks fall along with oil prices - Los Angeles Times
European Union
'Insane' for UK and EU to harm border trade, McLaren CEO says - CNBC
JUUL Labs, Inc.
Juul halts store sales of some flavored e-cigarettes - Associated Press
US Department of Defense (District of Columbia)
Who is Mira Ricardel and why did Melania Trump want her fired? - CNN
Paths to ANGLE plc
Potential Connections via
Relationship Science
You
ANGLE plc
Owners & Shareholders
Details Hidden
M. D. Barnard & Co. Ltd. (Investment Management)

MDB-IM is a risk-averse investment manager who follows a growth-oriented and flexible investment approach, focused on long-term capital appreciation. Their investment process consists of stock picking rather than focusing on specific sectors or market caps. Stock research is performed in house and often includes a company visit. Under unfavorable market conditions, the firm's portfolios are weighted in money-market instruments.The firm individually tailors portfolios to meet their clients' particular requirements. They avoid investment decisions based on rumored mergers and acquisitions, and generally dispose of underperforming assets. They have specific expertise in small-cap investing and manage diversified portfolios invested primarily in companies quoted on the AIM market.

Details Hidden
M. D. Barnard & Co. Ltd. (Investment Management)

MDB-IM is a risk-averse investment manager who follows a growth-oriented and flexible investment approach, focused on long-term capital appreciation. Their investment process consists of stock picking rather than focusing on specific sectors or market caps. Stock research is performed in house and often includes a company visit. Under unfavorable market conditions, the firm's portfolios are weighted in money-market instruments.The firm individually tailors portfolios to meet their clients' particular requirements. They avoid investment decisions based on rumored mergers and acquisitions, and generally dispose of underperforming assets. They have specific expertise in small-cap investing and manage diversified portfolios invested primarily in companies quoted on the AIM market.

Recent Transactions
Details Hidden

ANGLE plc purchases Axela, Inc. /Certain Assets from Axela, Inc.

Details Hidden

ANGLE plc issued Ordinary Shares

Details Hidden

SVF Holdco (UK) Ltd. purchases Geomerics Ltd. from ANGLE plc

Transaction Advisors
Broker
Cenkos Securities Plc (Broker)

Advised onANGLE plc issued Ordinary Shares

Legal Advisor
Pinsent Masons

Advised onANGLE plc issued Ordinary Shares

Auditor
RSM UK Group LLP

Advised onANGLE plc issued Ordinary Shares
Advisors & Consultants
Scientific Advisor
Ashok Venkitaraman

Chief Scientific Officer at Phoremost Ltd.

Scientific Advisor
Daniel C. Danila

Assistant Attending Physician at Memorial Sloan-Kettering Cancer Center

Scientific Advisor
Harold Swerdlow

Vice President, Sequencing at New York Genome Center, Inc.
Key Stats and Financials As of 2018
Market Capitalization
$66.2M
Total Enterprise Value
$37.1M
Earnings Per Share
$-0.08
Revenue
$628K
Net Profit
$-7.56M
EBITDA
$-9.46M
EBITDAMargin
-1,506.21%
Total Debt
$0
Total Equity
$15.9M
Enterprise Value Sales
59.02x
TEVNet Income
-4.91x
Debt TEV
0x
Five Year Compounded Annual Growth Rate Of Revenue
-8.31%
Three Year Compounded Annual Growth Rate Of Revenue
-14.65%

Creating a news feed is your most valuable research tool. RelSci sends you actionable updates so you can keep tabs on the people and organizations you care about most.

Browse in-depth profiles on 10 million influential people and organizations. Find RelSci relationships, employment history, board memberships, donations, awards, and more.

Explore notable alumni from top universities and organizations. Expand your fundraising pool and make warm introductions to potential new business connections.

Harness the power of your relationships with RelSci Pro, the powerful platform for identifying relationship-driven business opportunities and connections that can propel your career forward.

Creating a news feed is your most valuable research tool. RelSci sends you actionable updates so you can keep tabs on the people and organizations you care about most.

Browse in-depth profiles on 10 million influential people and organizations. Find RelSci relationships, employment history, board memberships, donations, awards, and more.

Explore notable alumni from top universities and organizations. Expand your fundraising pool and make warm introductions to potential new business connections.

Harness the power of your relationships with RelSci Pro, the powerful platform for identifying relationship-driven business opportunities and connections that can propel your career forward.